Molecular Dysregulation in Fuchs Corneal Endothelial Dystrophy
- Institution
- TRUSTEES OF INDIANA UNIVERSITY, IN
- Principal investigator
- Rajalekshmy Shyam
- Funding
- $239K
- Duration
- 2021–2026
Moonbase score
Still being scored
Abstract
Fuchs Endothelial Corneal Dystrophy (FECD) is a blinding disease that affects 4% over the age of 40 in the United States. There is no cure for this condition. Corneal tranplantation is the prevalent treatment. With the aging population, there is increasing scarcity of donor tissues. In addition, tranplant failures due to graft rejections occur in 10-25% of corneal transplantations. This proposal focuses on identifying previously understudied molecular signaling pathways in FECD. Successful completion of the specific aims in this proposal can lead to alternative therapies for FECD.
LOADING MOONBASE SCORE
Questions for TRUSTEES OF INDIANA UNIVERSITY
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · Trustees of Indiana University51
Multi-Scale Imaging Core (MSIC)
Hui-Chen Lu · $451K · 2023–2028
- NIH · Trustees of Indiana University48
Identifying Wolbachia effectors that facilitate host infection
Irene Newton · $375K · 2019–2029
- NIH · Trustees of Indiana University35
Early brain monitoring of infants with prenatal opioid exposure using quantitative diffuse optical spectroscopy
Silvina Ferradal · $251K · 2025–2027